| [1] |
Li Q Y, Gao B, Siqin B, He Q, Zhang R, Meng X X, Zhang N H, Zhang N, Li M H. Gut microbiota: A novel regulator of cardiovascular disease and key factor in the therapeutic effects of flavonoids[J]. Frontiers in Pharmacology, 2021, 12: 651926.
|
| [2] |
Lin L, Zhang J Q. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases[J]. BMC Immunology, 2017, 18(1): 2.
|
| [3] |
Gong L X, Wen T T, Wang J. Role of the microbiome in mediating health effects of dietary components[J]. Journal of Agricultural and Food Chemistry, 2020, 68(46)12820-12835.
|
| [4] |
Yang L, Gao Y C, Farag M A, Gong J P, Su Q L, Cao H, Zhang W, Zhao Y H, Wang H. Dietary flavonoids and gut microbiota interaction: A focus on animal and human studies to maximize their health benefits[J]. Food Frontiers, 2023, 4(4): 1794-1809.
|
| [5] |
Deng M, Jia X C, Dong L H, Liu L, Huang F, Chi J W, Ma Q, Zhao D, Zhang M W, Zhang R F. Structural elucidation of flavonoids from Shatianyu (Citrus grandis L. Osbeck) pulp and screening of key antioxidant components[J]. Food Chemistry, 2022, 366: 130605.
|
| [6] |
Deng M, Ye J M, Zhang R F, Zhang S, Dong L H, Su D X, Zhang M W, Huang F. Shatianyu (Citrus grandis L. Osbeck) whole fruit alleviated loperamide-induced constipation via enhancing gut microbiota-mediated intestinal serotonin secretion and mucosal barrier homeostasis[J]. Food & Function, 2024, 15(21): 10614-10627.
|
| [7] |
Singh S, Mishra S. Organoleptic and morphological analysis of Citrus peel powder[J]. Asian Food Science Journal, 2022: 1-11.
|
| [8] |
Gupta A K, Dhua S, Pratiksha, Kumar V, Naik B, Magwaza L S, Ncama K, Opara U L, McClements D J, Mishra P. Current and emerging applications in detection and removal of bitter compounds in Citrus fruit juice: A critical review[J]. Food Bioscience, 2023, 55: 102995.
|
| [9] |
|
|
Ye J M, Zhang M W, Lu Q, Zhang R F, Deng M. Effects of semi-solid fermentation with Lactobacillus on the bitterness and active components of Shatianyu ( Citrus grandis L. Osbeck) fruit powder[J]. Scientia Agricultura Sinica, 2024, 57(13): 2662-2673. DOI: 10.3864/j.issn.0578-1752.2024.13.013.(in Chinese)
|
| [10] |
He J, Zhang P W, Shen L Y, Niu L L, Tan Y, Chen L, Zhao Y, Bai L, Hao X X, Li X W, Zhang S H, Zhu L. Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism[J]. International Journal of Molecular Sciences, 2020, 21(17): 6356.
|
| [11] |
Hine A M, Loke P. Intestinal macrophages in resolving inflammation[J]. The Journal of Immunology, 2019, 203(3): 593-599.
|
| [12] |
Sittipo P, Shim J W, Lee Y K. Microbial metabolites determine host health and the status of some diseases[J]. International Journal of Molecular Sciences, 2019, 20(21): 5296.
|
| [13] |
Gomes J M G, de Assis Costa J, de Cássia Gonçalves Alfenas R. Metabolic endotoxemia and diabetes mellitus: A systematic review[J]. Metabolism, 2017, 68: 133-144.
|
| [14] |
Wassenaar T M, Zimmermann K. Lipopolysaccharides in food, food supplements, and probiotics: Should we be worried?[J]. European Journal of Microbiology & Immunology, 2018, 8(3): 63-69.
|
| [15] |
Gonçalves P, Araújo J R, di Santo J P. A cross-talk between microbiota-derived short-chain fatty acids and the host mucosal immune system regulates intestinal homeostasis and inflammatory bowel disease[J]. Inflammatory Bowel Diseases, 2018, 24(3): 558-572.
|
| [16] |
Xiong R G, Zhou D D, Wu S X, Huang S Y, Saimaiti A, Yang Z J, Shang A, Zhao C N, Gan R Y, Li H B. Health benefits and side effects of short-chain fatty acids[J]. Foods, 2022, 11(18): 2863.
|
| [17] |
Gasaly N, Hermoso M A, Gotteland M. Butyrate and the fine-tuning of colonic homeostasis: Implication for inflammatory bowel diseases[J]. International Journal of Molecular Sciences, 2021, 22(6): 3061.
|
| [18] |
Salvi P S, Cowles R A. Butyrate and the intestinal epithelium: Modulation of proliferation and inflammation in homeostasis and disease[J]. Cells, 2021, 10(7): 1775.
|
| [19] |
Hu M Y, Zhang L, Ruan Z, Han P H, Yu Y J. The regulatory effects of Citrus peel powder on liver metabolites and gut flora in mice with non-alcoholic fatty liver disease (NAFLD)[J]. Foods, 2021, 10(12): 3022.
|
| [20] |
Tung Y C, Chang W T, Li S M, Wu J C, Badmeav V, Ho C T, Pan M H. Citrus peel extracts attenuated obesity and modulated gut microbiota in mice with high-fat diet-induced obesity[J]. Food & Function, 2018, 9(6): 3363-3373.
|
| [21] |
Ferreira-Lazarte A, Plaza-Vinuesa L, de las Rivas B, Villamiel M, Muñoz R, Moreno F J. Production of α-rhamnosidases from Lactobacillus plantarum WCFS1 and their role in deglycosylation of dietary flavonoids naringin and rutin[J]. International Journal of Biological Macromolecules, 2021, 193: 1093-1102.
|
| [22] |
Wang Z W, Tang H R, Liu G W, Gong H X, Li Y G, Chen Y L, Yang Y X. Compound probiotics producing cellulase could replace cellulase preparations during solid-state fermentation of millet bran[J]. Bioresource Technology, 2023, 385: 129457.
|
| [23] |
Paiva F F, Vanier N L, De Jesus Berrios J, Pan J, de Almeida Villanova F, Takeoka G, Elias M C. Physicochemical and nutritional properties of pigmented rice subjected to different degrees of milling[J]. Journal of Food Composition and Analysis, 2014, 35(1): 10-17.
|
| [24] |
|
|
Wang L L, Zhang M W, Ye J M, Zhang R F, Deng M. Effects of soluble and insoluble dietary fiber from Shatianyu pulp on gut microbiota[J]. Scientia Agricultura Sinica, 2024, 57(20): 4119-4129. DOI: 10.3864/j.issn.0578-1752.2024.20.016.(in Chinese)
|
| [25] |
Cushnie T P T, Lamb A J. Antimicrobial activity of flavonoids[J]. International Journal of Antimicrobial Agents, 2005, 26(5): 343-356.
|
| [26] |
Gao P, Zheng M Y, Lu H Y, Lu S M. The progressive utilization of ponkan peel residue for regulating human gut microbiota through sequential extraction and modification of its dietary fibers[J]. Foods, 2023, 12(22): 4148.
|
| [27] |
Duda-Chodak A. The inhibitory effect of polyphenols on human gut microbiota[J]. Journal of Physiology and Pharmacology, 2012, 63(5): 497-503.
|
| [28] |
Ramos F M M, Ribeiro C B, Cesar T B, Milenkovic D, Cabral L, Noronha M F, Sivieri K. Lemon flavonoids nutraceutical (Eriomin®) attenuates prediabetes intestinal dysbiosis: A double-blind randomized controlled trial[J]. Food Science & Nutrition, 2023, 11(11): 7283-7295.
|
| [29] |
van den Broek L A, Hinz S W, Beldman G, Vincken J P, Voragen A G. Bifidobacterium carbohydrases-their role in breakdown and synthesis of (potential) prebiotics[J]. Molecular Nutrition & Food Research, 2008, 52(1): 146-163.
|
| [30] |
Xie Y X, Yang W J, Tang F, Chen X Q, Ren L C. Antibacterial activities of flavonoids: Structure-activity relationship and mechanism[J]. Current Medicinal Chemistry, 2014, 22(1): 132-149.
|
| [31] |
Araya-Cloutier C, Vincken J P, van de Schans M G M, Hageman J, Schaftenaar G, den Besten H M W, Gruppen H. QSAR-based molecular signatures of prenylated (iso)flavonoids underlying antimicrobial potency against and membrane-disruption in Gram positive and Gram negative bacteria[J]. Scientific Reports, 2018, 8: 9267.
|
| [32] |
Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso L R, Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: A narrative review[J]. Internal and Emergency Medicine, 2024, 19(2): 275-293.
|
| [33] |
Xiao X Y, Singh A, Giometto A, Brito I L. Segatella clades adopt distinct roles within a single individual’s gut[J]. npj Biofilms and Microbiomes, 2024, 10: 114.
|
| [34] |
Qu Y F, Li X Y, Xu F Y, Zhao S M, Wu X M, Wang Y Z, Xie J M. Kaempferol alleviates murine experimental colitis by restoring gut microbiota and inhibiting the LPS-TLR4-NF-κB axis[J]. Frontiers in Immunology, 2021, 12: 679897.
|
| [35] |
Zhan J, Liang Y R, Liu D H, Ma X R, Li P Z, Zhai W J, Zhou Z Q, Wang P. Pectin reduces environmental pollutant-induced obesity in mice through regulating gut microbiota: A case study of p, p′-DDE[J]. Environment International, 2019, 130: 104861.
|
| [36] |
Gomez-Arango L F, Barrett H L, Wilkinson S A, Callaway L K, McIntyre H D, Morrison M, Dekker Nitert M. Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women[J]. Gut Microbes, 2018, 9(3): 189-201.
|
| [37] |
Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, Hayek J, Jousson O, Leoncini S, Renzi D, Calabrò A, De Filippo C. New evidences on the altered gut microbiota in autism spectrum disorders[J]. Microbiome, 2017, 5(1): 24.
|
| [38] |
Mena-Vázquez N, Ruiz-Limón P, Moreno-Indias I, Manrique-Arija S, Lisbona-Montañez J M, Rioja J, Mucientes A, Martin-Núñez G M, Cano-García L, Tinahones F J, Fernández-Nebro A. Adiposity is associated with expansion of the genus Dialister in rheumatoid arthritis patients[J]. Biomedicine & Pharmacotherapy, 2023, 160: 114388.
|
| [39] |
Tito R Y, Cypers H, Joossens M, Varkas G, Van Praet L, Glorieus E, van den Bosch F, De Vos M, Raes J, Elewaut D. Brief report: Dialister as a microbial marker of disease activity in spondyloarthritis[J]. Arthritis & Rheumatology, 2017, 69(1): 114-121.
|